Related Experiment Video
Updated: Feb 10, 2026

G Protein-selective GPCR Conformations Measured Using FRET Sensors in a Live Cell Suspension Fluorometer Assay
Published on: September 10, 2016
Antibodies Against GPCR.
Carlotto Meyer1, Harald Heidecke2
1CellTrend GmbH, Im Biotechnologiepark TGZ II, 14943 Luckenwalde, Germany.
Auto-antibodies targeting G-protein-coupled receptors (GPCRs) can activate specific pathways, contributing to various diseases. This review explores the role of these activating anti-GPCR auto-antibodies in transplantation, autoimmune disorders, cardiovascular conditions, neurodegenerative diseases, and cancer.
Area of Science:
- Immunology
- Molecular Biology
- Pathophysiology
Background:
- G-protein-coupled receptors (GPCRs) are crucial cell surface receptors involved in numerous physiological processes.
- Auto-antibodies (aab) can bind to GPCRs, acting as ligands and modulating receptor activity.
- Dysregulated GPCR signaling by auto-antibodies is implicated in the pathogenesis of diverse diseases.
Purpose of the Study:
- To review current knowledge on antibodies targeting GPCRs.
- To elucidate the effects and relevance of anti-GPCR auto-antibodies in disease pathogenesis.
- To discuss the diagnostic and therapeutic potential of targeting GPCR-directed auto-antibodies.
Main Methods:
- Literature review of studies investigating auto-antibodies against GPCRs.
- Analysis of the role of activating anti-GPCR auto-antibodies in various clinical conditions.
- Synthesis of information on the clinical relevance and diagnostic applications.
Main Results:
- Activating anti-GPCR auto-antibodies play a significant role in conditions such as solid organ and stem cell transplantations.
- These auto-antibodies are implicated in systemic sclerosis, preeclampsia, chronic fatigue syndrome, cardiovascular diseases, Alzheimer's disease, and cancer.
- Specific cellular pathways are activated by distinct auto-antibodies targeting GPCRs.
Conclusions:
- Auto-antibodies targeting GPCRs represent a significant factor in the pathogenesis of a wide range of diseases.
- Understanding these interactions is crucial for developing novel diagnostic tools and therapeutic strategies.
- Targeting GPCR-directed auto-antibodies holds promise for clinical diagnostics and treatment across multiple medical fields.
Related Concept Videos
GPCR Desensitization
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Cell-surface Signaling
G-protein Coupled Receptors

